Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s New ‘N of 1’ Guidance Essentially A Down Payment On Critical Advice
Jan 05 2021
•
By
Sarah Karlin-Smith
More from Cell & Gene Therapies
More from Advanced Technologies